Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
iTeos Therapeutics, Inc. | Chief Executive Officer | Common Stock | 58.9K | $493K | $8.37 | Dec 5, 2023 | Direct |
iTeos Therapeutics, Inc. | Chief Executive Officer | Stock Option (Right to Buy) | 443K | Aug 8, 2024 | By MG3A | ||
iTeos Therapeutics, Inc. | Chief Executive Officer | Stock Option (Right to Buy) | 148K | Aug 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ITOS | iTeos Therapeutics, Inc. | Aug 8, 2024 | 2 | $0 | 4 | Aug 9, 2024 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Mar 7, 2024 | 1 | $0 | 4 | Mar 8, 2024 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Dec 5, 2023 | 1 | $0 | 4 | Dec 7, 2023 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Mar 9, 2023 | 3 | $0 | 4 | Mar 10, 2023 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Dec 31, 2022 | 2 | $0 | 5 | Mar 10, 2023 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Apr 18, 2022 | 4 | -$318K | 4 | Apr 19, 2022 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Mar 21, 2022 | 4 | -$630K | 4 | Mar 22, 2022 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Mar 11, 2022 | 2 | $0 | 4 | Mar 14, 2022 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Feb 23, 2022 | 2 | -$498K | 4 | Feb 24, 2022 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Jan 25, 2022 | 2 | -$517K | 4 | Jan 26, 2022 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Dec 2, 2021 | 23 | -$1.85M | 4 | Dec 22, 2021 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Nov 22, 2021 | 3 | -$321K | 4 | Nov 24, 2021 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Nov 1, 2021 | 3 | -$587K | 4 | Nov 3, 2021 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Oct 21, 2021 | 1 | -$5.49K | 4 | Oct 25, 2021 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Oct 15, 2021 | 2 | -$51.4K | 4 | Oct 19, 2021 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Sep 23, 2021 | 2 | -$180K | 4 | Sep 27, 2021 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Sep 1, 2021 | 3 | -$581K | 4 | Sep 3, 2021 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Aug 27, 2021 | 3 | -$412K | 4 | Aug 31, 2021 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Aug 23, 2021 | 3 | -$241K | 4 | Aug 25, 2021 | Chief Executive Officer |
ITOS | iTeos Therapeutics, Inc. | Jun 14, 2021 | 2 | -$827K | 4 | Jun 16, 2021 | Chief Executive Officer, Director |